Drug Shortage Report for RAPAMUNE

Last updated on 2021-11-25 History
Report ID 149855
Drug Identification Number 02243237
Brand name RAPAMUNE
Common or Proper name RAPAMUNE
Company Name PFIZER CANADA ULC
Market Status MARKETED
Active Ingredient(s) SIROLIMUS
Strength(s) 1.0MG
Dosage form(s) SOLUTION
Route of administration ORAL ORAL
Packaging size 60ML
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-11-24
Estimated end date 2022-03-15
Actual end date
Shortage status Actual shortage
Updated date 2021-11-25
Company comments On preventive allocation Our other presentation 1mg Tablet remain available
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-11-25 English Compare
v2 2021-11-24 French Compare
v1 2021-11-24 English Compare